{"product_id":"executive-brain-span-audit-mci","title":"Executive Brain-Span Audit (MCI)","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e The Executive Brain-Span Audit (MCI) is a clinical-grade cognitive screening service offered by EMIS+ in Singapore, designed to detect early-stage Mild Cognitive Impairment through standardised neuropsychological testing batteries covering executive function, memory recall, and processing speed. The assessment follows internationally recognised MCI diagnostic criteria aligned with the National Institute on Aging and Alzheimer's Association (NIA-AA) research framework. It is indicated for adults aged 40 and above seeking proactive cognitive health monitoring, particularly those with cardiovascular risk factors, family history of neurodegenerative disease, or occupational cognitive demands.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThe Executive Brain-Span Audit (MCI) at EMIS+ is a comprehensive cognitive health assessment service available exclusively through emis.asia in Singapore. This clinical-grade screening protocol employs validated neuropsychological instruments to evaluate executive function, episodic memory, visuospatial ability, language fluency, and processing speed. The assessment generates a personalised brain longevity profile that quantifies cognitive reserve and identifies domains requiring targeted intervention.\u003c\/p\u003e\n\u003cp\u003eEarly detection of Mild Cognitive Impairment represents a critical window for therapeutic intervention. Peer-reviewed longitudinal studies demonstrate that individuals identified at the MCI stage who receive structured cognitive rehabilitation, lifestyle modification, and pharmacological support where appropriate experience significantly better cognitive trajectories than those diagnosed after progression to dementia. The EMIS+ protocol integrates evidence-based screening methodologies consistent with NIA-AA 2018 research framework criteria and Singapore Ministry of Health (MOH) clinical practice guidelines for dementia management.\u003c\/p\u003e\n\u003ch2\u003eService Specifications\u003c\/h2\u003e\n\u003ctable style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\"\u003e\n\u003ctbody\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold; width: 40%;\"\u003eProvider\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eEMIS+ (Essential Medical International Supplies Pte Ltd), Singapore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eAssessment Type\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eNeuropsychological Screening Battery — Mild Cognitive Impairment (MCI)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eCognitive Domains Assessed\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eExecutive Function, Episodic Memory, Working Memory, Processing Speed, Visuospatial Function, Language Fluency\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eValidated Instruments\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eMoCA (Montreal Cognitive Assessment), Trail Making Test (TMT-A\/B), Digit Span, Category Fluency\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eDiagnostic Framework\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eNIA-AA 2018 Research Framework; DSM-5 Mild Neurocognitive Disorder Criteria\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eTarget Population\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eAdults aged 40+; individuals with cardiovascular risk factors, family history of neurodegeneration, or high cognitive occupational demands\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eDelivery\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eIn-person clinical assessment, Singapore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eOutput\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003ePersonalised Brain Longevity Profile with domain-specific scoring and intervention recommendations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003eRegulatory Alignment\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eSingapore MOH Clinical Practice Guidelines on Dementia; NIA-AA 2018 Framework; ISO 15189 accredited laboratory partners where applicable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr style=\"border-bottom: 1px solid #ddd;\"\u003e\n\u003ctd style=\"padding: 8px; font-weight: bold;\"\u003ePrice\u003c\/td\u003e\n\u003ctd style=\"padding: 8px;\"\u003eSGD 179.00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eProactive cognitive health screening for adults aged 40 and above as part of annual executive health programmes\u003c\/li\u003e\n\u003cli\u003eEarly detection of Mild Cognitive Impairment in individuals presenting with subjective memory complaints not yet meeting dementia diagnostic thresholds\u003c\/li\u003e\n\u003cli\u003eBaseline cognitive profiling for patients initiating cardiovascular, metabolic, or neurological treatment protocols where cognitive monitoring is recommended\u003c\/li\u003e\n\u003cli\u003ePost-concussion or post-anaesthetic cognitive function assessment to establish recovery benchmarks\u003c\/li\u003e\n\u003cli\u003eLongitudinal cognitive monitoring for individuals with APOE-e4 carrier status or first-degree family history of Alzheimer disease\u003c\/li\u003e\n\u003cli\u003eOccupational cognitive fitness evaluation for professionals in safety-critical roles (aviation, healthcare, finance)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the clinical basis for MCI screening at age 40?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: The NIA-AA 2018 research framework and epidemiological data from the Singapore Longitudinal Ageing Study (SLAS) indicate that subclinical cognitive changes can begin in the fourth decade. Early screening establishes a cognitive baseline that enables detection of meaningful decline over time, consistent with recommendations from the American Academy of Neurology (AAN) practice parameter on MCI.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Which neuropsychological instruments are used in this audit?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: The assessment employs internationally validated tools including the Montreal Cognitive Assessment (MoCA), Trail Making Test Parts A and B, Digit Span Forward and Backward, and Category Fluency testing. These instruments are recommended by the Singapore MOH Clinical Practice Guidelines on Dementia and align with NIA-AA core clinical criteria for MCI diagnosis.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does this differ from a standard memory screening?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Standard memory screenings such as the MMSE assess global cognitive function with limited sensitivity for MCI. The Executive Brain-Span Audit employs a multi-domain neuropsychological battery with specific attention to executive function — the cognitive domain most predictive of functional decline and occupational performance deterioration in early MCI presentations.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is this assessment recognised by Singapore healthcare authorities?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: The screening instruments and diagnostic criteria used are consistent with Singapore Ministry of Health (MOH) Clinical Practice Guidelines on Dementia and internationally recognised frameworks (NIA-AA, DSM-5). Results can be shared with referring physicians for clinical decision-making and further diagnostic workup including neuroimaging if indicated.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can I use MediFund, MediSave, or insurance to pay for this assessment?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA: Cognitive screening services may qualify for reimbursement under certain private health insurance plans or corporate wellness programmes. MediSave coverage for cognitive screening is subject to MOH regulations and referring physician assessment. Please consult your insurance provider or contact EMIS+ at emis.asia for specific coverage enquiries.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is Executive Brain-Span Audit (MCI) used for?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Executive Brain-Span Audit (MCI) by EMIS + is an ostomy care product designed to support stoma management and protect peristomal skin. It is suitable for use with colostomy, ileostomy, and urostomy pouching systems. For personalised advice on your pouching system, consult a Wound, Ostomy and Continence (WOC) nurse at SGH, NUH, CGH, or TTSH in Singapore.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Executive Brain-Span Audit (MCI) suitable for all stoma types — colostomy, ileostomy, and urostomy?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Most EMIS + stoma care products are designed to be compatible with all stoma types. However, the right product depends on your individual stoma location, output type, and skin condition. An enterostomal therapist (ET nurse) at a Singapore hospital can help you select the most appropriate products for your specific pouching system.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How do I use Executive Brain-Span Audit (MCI) correctly?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Always refer to the product instructions included with Executive Brain-Span Audit (MCI). In general, ensure peristomal skin is clean and dry before application, measure your stoma accurately, and change your pouching system every 1–3 days or when leakage is suspected. If you experience peristomal skin irritation, soreness, or persistent leakage, contact a WOC nurse or EMIS+ team for advice.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Executive Brain-Span Audit (MCI) in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Executive Brain-Span Audit (MCI) is available from EMIS+ at emis.asia — Singapore's trusted nurse-led stoma supply store. We stock a comprehensive range of ostomy products with fast island-wide delivery. Bulk orders for home care and nursing facilities are welcome. Contact us at emis.asia\/pages\/contact.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"EMIS +","offers":[{"title":"Default Title","offer_id":43526346440782,"sku":null,"price":179.0,"currency_code":"SGD","in_stock":true}],"url":"https:\/\/www.emis.asia\/products\/executive-brain-span-audit-mci","provider":"EMIS +","version":"1.0","type":"link"}